CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q2 2022. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,158,217 | -19.9% | 25,517 | -1.0% | 0.30% | -19.6% |
| Q2 2023 | $1,446,841 | +27.6% | 25,772 | +2.8% | 0.37% | +27.4% |
| Q1 2023 | $1,133,555 | +8.8% | 25,062 | -2.2% | 0.29% | +5.8% |
| Q4 2022 | $1,041,900 | -40.2% | 25,631 | -3.9% | 0.28% | -41.0% |
| Q3 2022 | $1,743,000 | +2.8% | 26,668 | -4.4% | 0.47% | +12.8% |
| Q2 2022 | $1,695,000 | -3.5% | 27,895 | -0.3% | 0.42% | +3.0% |
| Q1 2022 | $1,756,000 | -6.0% | 27,979 | +13.5% | 0.40% | -2.2% |
| Q4 2021 | $1,868,000 | -29.0% | 24,652 | +4.9% | 0.41% | -33.8% |
| Q3 2021 | $2,631,000 | -30.2% | 23,504 | +0.9% | 0.62% | -29.4% |
| Q2 2021 | $3,769,000 | +17.8% | 23,283 | -11.3% | 0.88% | +12.4% |
| Q1 2021 | $3,200,000 | -8.8% | 26,263 | +14.6% | 0.78% | -20.3% |
| Q4 2020 | $3,508,000 | +76.2% | 22,914 | -3.7% | 0.98% | +47.3% |
| Q3 2020 | $1,991,000 | -29.2% | 23,806 | -37.8% | 0.67% | -34.3% |
| Q2 2020 | $2,811,000 | +72.9% | 38,253 | -0.2% | 1.02% | +41.9% |
| Q1 2020 | $1,626,000 | – | 38,344 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |